Compare Strategy Inc. (MSTR) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs 10X Genomics Inc — how do they compare? Strategy Inc. trades at $102.05 (market cap $35.47B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Strategy Inc. is far larger — about 6.5× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| MSTR | TXG | |
|---|---|---|
Market Cap | $35.47B | $5.48B |
Sector | Technology | Health |
52-Week High | $426.40 | $45.80 |
52-Week Low | $82.31 | $11.34 |
Enterprise Value | $50.50B | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
